January 26, 2023 08:08 AM ESTUpdated February 7, 09:30 AM

#JPM23: What's re­al­ly dri­ving the cost of health­care and drugs in 2023?

Drew Armstrong

Executive Editor

Ex­ec­u­tive Ed­i­tor Drew Arm­strong spoke with PhRMA CEO Steve Ubl, Em­sa­naRx CEO Greg Bak­er and ICER Pres­i­dent Steve Pear­son about how the de­bate over drug …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ideaya inks ADC deal with $75M up­front; Amy­lyx, Gubra to de­vel­op long-act­ing GLP-1

De­spite mixed da­ta in Alzheimer's ag­i­ta­tion, Ax­some will still seek FDA ap­proval

FDA ap­proves sub­cu­ta­neous ver­sion of Bris­tol My­er­s' Op­di­vo

BioN­Tech set­tles with NIH, UPenn in Covid vac­cine dis­putes and will pay roy­al­ties

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

WuXi AppTec will sell cell and gene ther­a­py busi­ness to pri­vate eq­ui­ty firm

A service from the Financial Times